Modulation of Lymphotoxin β Surface Expression by Kaposi's Sarcoma‐Associated Herpesvirus K3 Through Glycosylation Interference
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Soowon Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, …. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immune Evasion, Viral Proteins, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, This study was supported by grants from the US National Institutes of Health (NIH) CA251275, CA294881, AI152190, AI17120, AI181758, DE023926, DE028521, and U01…, NIAID NIH HHS.
Abstract (Originalsprache)
Kaposi's sarcoma‐associated herpesvirus (KSHV) employs diverse mechanisms to subvert host immune responses, contributing to its infection and pathogenicity. As an immune evasion strategy, KSHV encodes the Membrane‐Associated RING‐CH (MARCH)‐family E3 ligases, K3, and K5, which target and remove several immune regulators from the cell surface. In this study, we investigate the impact of K3 and K5 on lymphotoxin receptor (LTβR) ligands, LTβ and LIGHT, which are type II transmembrane proteins and function as pivotal immune mediators during virus infection. Upon co‐expression of viral MARCH proteins with LTβR ligands, we showed that K3 and K5 selectively targeted LTβ, but not LIGHT, for the downregulation of surface expression. Specifically, K3 and K5 E3 ligases interacted with the transmembrane domain of LTβ. Intriguingly, K3 interacted with an immature form of LTβ, whereas K5 targeted the fully mature form. Subsequent biochemical analyses revealed that K3 disrupted the initial steps of N‐glycosylation maturation of LTβ. This interference resulted in the sequestration of LTβ within the endoplasmic reticulum, impeding its trafficking to the plasma membrane. Consequently, the K3‐mediated downregulation of LTβ surface expression suppressed the LTβR downstream signaling pathway. These findings uncover a novel mechanism by which KSHV K3 E3 ligase inhibits the membrane trafficking pathway of the LTβ inflammatory ligand through glycosylation interference, potentially evading LTβR‐mediated antiviral immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Medicine, Division of Rheumatology, Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Förderung
- NCI NIH HHS
- This study was supported by grants from the US National Institutes of Health (NIH) CA251275, CA294881, AI152190, AI17120, AI181758, DE023926, DE028521, and U01…
- NIAID NIH HHS
- NIDCR NIH HHS
- National Institutes of Health
Zitieren
APA
Kang, S., Brulois, K., Choi, Y. J., Zhang, S., & Jung, J. U. (2025). Modulation of Lymphotoxin β Surface Expression by Kaposi's Sarcoma‐Associated Herpesvirus K3 Through Glycosylation Interference. Journal of Medical Virology. https://doi.org/10.1002/jmv.70179
Vancouver
Kang S, Brulois K, Choi YJ, Zhang S, Jung JU. Modulation of Lymphotoxin β Surface Expression by Kaposi's Sarcoma‐Associated Herpesvirus K3 Through Glycosylation Interference. Journal of Medical Virology. 2025. doi:10.1002/jmv.70179
BibTeX
@article{Kang2025,
author = {Kang, Soowon and Brulois, Kevin and Choi, Youn Jung and Zhang, Shaoyan and Jung, Jae U},
title = {Modulation of Lymphotoxin β Surface Expression by Kaposi's Sarcoma‐Associated Herpesvirus K3 Through Glycosylation Interference},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70179}
}
EUVIMED